Status:
COMPLETED
Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Chordoma
Eligibility:
All Genders
Up to 110 years
Brief Summary
Chordoma is an uncommon (400 case/year in the U.S.) and potentially fatal bone tumor derived from remnants of embryonic notochord. It occurs primarily in the axial skeleton and has a mean age at diagn...
Detailed Description
Chordoma is an uncommon (400 case/year in the U.S.) and potentially fatal bone tumor derived from remnants of embryonic notochord. It occurs primarily in the axial skeleton and has a mean age at diagn...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- All persons with chordoma reported to the four tumor registries from January 1988 to the end of the study period.
Exclusion
Key Trial Info
Start Date :
February 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 6 2020
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00341627
Start Date
February 1 1999
End Date
July 6 2020
Last Update
July 10 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242
2
NCI, DCEG, Clinical Genetics Branch
Rockville, Maryland, United States, 20850